International Conference on Clinical Gynecology and Women Oncology (ICCGWO)

  01 Jul 2025 - 02 Jul 2025

   Barcelona, Spain

conference-img

International Conference on Clinical Gynecology and Women Oncology (ICCGWO)

01 Jul 2025

 - 

02 Jul 2025

Barcelona, Spain



ICCGWO focuses on the latest developments in gynecological health and oncology. Experts will discuss innovative treatments, clinical research, and advancements in women's cancer care.

The conference will highlight advances in gynecologic oncology, cervical and ovarian cancer research, and innovations in minimally invasive surgery. Attendees will explore critical discussions on women's reproductive health, fertility preservation, and screening and early detection strategies to enhance patient outcomes.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


ASCO Annual Meeting 2026

On: 29 May 2026

-

02 Jun 2026


International Conference on Medical and Health Sciences

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Diabetes Endocrinology and Obesity

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Virology and Immunology

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


ASCO Annual Meeting 2026

On: 29 May 2026

-

02 Jun 2026


International Conference on Medical and Health Sciences

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Diabetes Endocrinology and Obesity

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Virology and Immunology

On: 01 Jun 2026

-

01 Jun 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot